Fibrobiologics Inc (FBLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 2,093 | 2,265 | 0 | 0 |
| Operating Income | -2,093 | -2,265 | N/A | N/A |
| Interest Expense | 10 | 135 | 0 | 0 |
| Other Income | -57 | -15 | 0 | 0 |
| Pre-tax Income | -2,160 | -2,415 | 0 | 0 |
| Net Income Continuous | -2,160 | -2,415 | N/A | N/A |
| Net Income | $-2,160 | $-2,415 | $N/A | $N/A |
| EPS Basic Total Ops | -1.60 | -3.60 | N/A | N/A |
| EPS Basic Continuous Ops | -1.53 | -1.71 | N/A | N/A |
| EPS Diluted Total Ops | -1.60 | -3.60 | N/A | N/A |
| EPS Diluted Continuous Ops | -1.53 | -1.71 | N/A | N/A |
| EBITDA(a) | $-1,991 | $-2,091 | $N/A | $N/A |